Vicarious Surgical Inc (NYSE:RBOT - Get Free Report)'s share price was up 9.7% on Monday . The stock traded as high as $18.97 and last traded at $16.02. Approximately 173,304 shares changed hands during mid-day trading, an increase of 78% from the average daily volume of 97,335 shares. The stock had previously closed at $14.61.
Wall Street Analyst Weigh In
Separately, Piper Sandler decreased their price target on Vicarious Surgical from $12.00 to $10.50 and set a "neutral" rating on the stock in a report on Wednesday, November 13th.
Get Our Latest Research Report on Vicarious Surgical
Vicarious Surgical Trading Down 6.3 %
The firm has a market capitalization of $88.62 million, a P/E ratio of -1.46 and a beta of 1.32. The company has a 50 day simple moving average of $12.00 and a two-hundred day simple moving average of $8.60.
Vicarious Surgical Company Profile
(
Get Free Report)
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Recommended Stories
Before you consider Vicarious Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vicarious Surgical wasn't on the list.
While Vicarious Surgical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
